Zielinska M, Haegele N F, Firschke C
Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse 36, D-80636 München, Germany.
Heart. 2001 Nov;86(5):E16. doi: 10.1136/heart.86.5.e16.
In patients with prosthetic heart valves non-cardiac surgery may require temporary discontinuation of oral anticoagulation. Although the risk of valve related thromboembolic complications may generally be only slightly increased during the short perioperative period, in the presence of certain risk factors, replacement of oral anticoagulation with heparin is recommended. In the presented patient, unusually fulminant and finally fatal thrombosis of a mechanical mitral valve prosthesis developed within only 48 hours after non-cardiac surgery despite heparin treatment. The thrombosis was triggered by clinical conditions favouring a hypercoagulable state. This report dramatically shows that despite improvements in prosthetic heart valve design and in the management of anticoagulation, thrombosis remains one of the most dangerous complications after valve replacement with a mechanical prosthesis.
对于接受人工心脏瓣膜置换的患者,非心脏手术可能需要暂时停用口服抗凝药。尽管在围手术期短时间内瓣膜相关血栓栓塞并发症的风险通常仅略有增加,但在存在某些危险因素的情况下,建议用肝素替代口服抗凝药。在本病例患者中,尽管接受了肝素治疗,但在非心脏手术后仅48小时内就发生了机械二尖瓣假体异常暴发性且最终致命的血栓形成。血栓形成是由有利于高凝状态的临床情况触发的。本报告有力地表明,尽管人工心脏瓣膜设计和抗凝管理有所改进,但血栓形成仍然是机械假体瓣膜置换术后最危险的并发症之一。